MAGPIE PHARMACEUTICALS
Magpie Pharmaceuticals specialize in the research and development of first-in-class drugs. The company focuses on the structural modification and transformation of active natural product monomers in traditional Chinese medicines (TCM), as well as small molecular compounds currently in clinical use.
MAGPIE PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Guangzhou, Guangdong, China
Country:
China
Website Url:
http://www.magpiepharma.com
Total Employee:
51+
Status:
Active
Total Funding:
28.79 M USD
Technology used in webpage:
SSL By Default Nginx Sectigo SSL Sectigo Domain SSL Baidu Cloud West263
Similar Organizations
BIG Pharmacy
BIG Pharmacy operates as a pharma retailer.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Furley Bioextracts
Furley Bioextracts is a biotechnology manufacturer.
Magalarva
Magalarva is a biotechnology company located in Jakarta.
Northeast Pharmaceutical Group
Northeast Pharmaceutical Group is a Biotechnology Company.
QnQuality Pharmaceuticals
QnQuality Pharmaceuticals is a drug R&D company.
Splash Pharmaceuticals
Splash Pharmaceuticals is a clinical stage oncology company.
Current Employees Featured
Founder
Investors List
Canton Venture Capital
Canton Venture Capital investment in Series C - Magpie Pharmaceuticals
Zhejiang Conba Pharmaceutical
Zhejiang Conba Pharmaceutical investment in Series C - Magpie Pharmaceuticals
BOC & Utrust Private Equity Fund Management
BOC & Utrust Private Equity Fund Management investment in Series C - Magpie Pharmaceuticals
Sangel Capital
Sangel Capital investment in Series B - Magpie Pharmaceuticals
Wonderland Capital
Wonderland Capital investment in Series A - Magpie Pharmaceuticals
Beijing Prudential Capital Management
Beijing Prudential Capital Management investment in Series A - Magpie Pharmaceuticals
Official Site Inspections
http://www.magpiepharma.com
- Host name: 47.90.247.155
- IP address: 47.90.247.155
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Magpie Pharmaceuticals"
广州喜鹊医药有限公司
喜鹊医药成立于2011年，总部位于广州科学城，是国内最早从事创新药物开发的企业之一。 秉持“求真务实，临床需求导向”的价值理念，依托独特的“中药源”小分子创新药物开发平台，设计 …See details»
广州喜鹊医药有限公司 - magpiepharma.com
广州喜鹊医药有限公司 (简称喜鹊医药)是由国际知名药物化学家王玉强教授创办的临床阶段“First-in-Class”创新药物研究开发企业。 秉持“求真务实，临床需求导向”的价值理念，基于小分子创新药物研究开发平台，喜鹊医药已经在心、脑血 …See details»
Magpie Pharmaceuticals CO. LTD. - BIO International Convention
Jun 7, 2023 · Guangzhou Magpie Pharmaceuticals, Inc. (MPI) is a clinical stage drug discovery and development company. MPI focuses on developing novel treatments for cerebro …See details»
Magpie Pharmaceuticals - VentureRadar
Website: http://magpiepharma.com/ Develops innovative drugs for medical conditions like ALS, hypertension, vascular dementia, and diabetic nephropathy, with flagship product MN-08. …See details»
Guangzhou Magpie Pharmaceuticals Co., Ltd. - BIO International ...
Jun 5, 2024 · Guangzhou Magpie Pharmaceuticals Co., Ltd. (MPI) is a leading biotech company in Guangzhou, China with a robust pipeline of late-stage clinical assets. MPI focuses on …See details»
Magpie Pharmaceuticals - VentureRadar
Website: http://magpiepharma.com/ Develops class 1 chemical drugs for treating cardiovascular, cerebrovascular, and mitochondrial diseases, including stroke, diabetic nephropathy, …See details»
Magpie Pharmaceuticals - Crunchbase Company …
Magpie Pharmaceuticals is a biotechnology company. Magpie Pharmaceuticals specialize in the research and development of first-in-class drugs. The company focuses on the structural modification and transformation of active natural …See details»
Guangzhou Magpie Pharmaceuticals Co., Ltd. - synapse.zhihuiya.com
喜鹊医药创始人、董事长兼总经理、CNS创业社社长王玉强教授领衔策划CNS领域创新实践主题研讨活动，以《阿尔茨海默病药物研发的创新路径与实践》为题发表主题演讲，并参与圆桌讨论 …See details»
广州喜鹊医药有限公司 - magpiepharma.com
TBN可通过清除自由基上调AMPK/NRF2信号通路来保护肾脏细胞；抑制mTOR，激活自噬，清除损伤的肾脏细胞；以及促进线粒体生物合成、抑制钙通道和抑制炎性反应等多种作用机理，改 …See details»
Guangzhou Magpie Pharmaceuticals Co., Ltd. - Drug pipelines, …
Results indicated that T-006 treatment significantly improved neurological function and behavior. Double immunofluorescence staining showed that T-006 visibly improved the number of …See details»
Magpie Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Magpie Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Magpie Pharmaceuticals - Products, Competitors, Financials, …
Magpie Pharmaceuticals is a clinical-stage company focused on the development of First-in-Class innovative drugs within the pharmaceutical industry.See details»
广州喜鹊医药有限公司 - magpiepharma.com
在美国加州硅谷从事创新药物研究开发多年，是治疗阿尔兹海默症“重磅炸弹”药物美金刚原研团队重要成员。 回国后获聘暨南大学教授，博士生导师，药学院首任院长，2011年创办广州喜鹊 …See details»
Overview, News & Similar companies - ZoomInfo.com
View Magpie Pharmaceuticals (www.magpiepharma.com) location in Guangdong, China , revenue, industry and description. Find related and similar companies as well as employees …See details»
Guangzhou Magpie Pharmaceuticals - Apollo.io
View Guangzhou Magpie Pharmaceuticals (http://www.magpiepharma.com) location in Guangdong, China, revenue, competitors and contact information. Find and reach Guangzhou …See details»
Guangzhou Magpie Pharmaceuticals presents Phase II Clinical
Oct 2, 2023 · Guangzhou Magpie Pharmaceuticals announced its submission of a poster presentation at the XXVI World Congress of Neurology (WCN 2023), showcasing Phase II …See details»
广州喜鹊医药有限公司 - magpiepharma.com
TBN是喜鹊医药自主研究开发的1类创新化学药物，是一个多功能神经保护剂，具有高效的自由基清除作用，可改善线粒体功能、增加ATP产生、促进细胞自噬和神经再生。 TBN用于治疗急 …See details»
Chinese Biotech Firm Magpie Pharmaceuticals Raises Nearly $15M …
Feb 13, 2019 · Guangzhou-based biotechnology company Magpie Pharmaceuticals announced on Monday that it has raised a nearly RMB100 million (US$14.8 million) series B ... America, …See details»
广州喜鹊医药有限公司 - magpiepharma.com
肌萎缩侧索硬化症 (ALS)，俗称“渐冻人症”，是一种以脑和脊髓运动神经元的进行性退化为特征的致死性神经退行性疾病。 ALS是一种罕见病，该病进展迅速，患者的平均生存期仅约为3-5 …See details»